Northvale, New Jersey--(Newsfile Corp. - August 4, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,
Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report)'s stock price passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.38 and traded a

Possible Generic Drug Tariffs and 2 Microcaps

03:11am, Friday, 31'st Jul 2026
Generic drug tariffs could impact ELTP and CPIX.
Elite Pharmaceuticals and Cumberland Pharmaceuticals follow different growth paths, but which looks more compelling now? Let's dive in.
ELTP delivers record fiscal 2026 results, with stronger profits, improved cash and pipeline progress supporting its expanding generics platform.
Elite Pharmaceuticals, Inc. (ELTP) Q4 2026 Earnings Call Transcript
Conference Call Scheduled for Tuesday, June 30 at 11:30 AM EDT Northvale, New Jersey--(Newsfile Corp. - June 29, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specia
Financials for Fiscal Year 2026 Ended March 31, 2026 will be released on Monday, June 29, 2026 Northvale, New Jersey--(Newsfile Corp. - June 23, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Eli
Northvale, New Jersey--(Newsfile Corp. - June 15, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufact
Northvale, New Jersey--(Newsfile Corp. - June 1, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufactu
Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) and Rafael (NYSE: RFL - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses
Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report)'s stock price passed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $0.40 and trad
Northvale, New Jersey--(Newsfile Corp. - April 2, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,
Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report) shares passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $0.52 and
ELTP reports surging revenue and profit in third-quarter fiscal 2026, but margin pressure and M&A ambitions steal the spotlight.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE